References
1. Klimpel GR (1996) Immune Defenses. In:
Baron S, ed. Medical Microbiology. 4th
ed. Galveston (TX): University of Texas Medical Branch at Galveston, https://pubmed.ncbi.
nlm.nih.gov/21413332/
2. Cox JH, Ferrari G, Janetzki S (2006) Measurement of cytokine release at the single cell level
using the ELISPOT assay. Methods
38:274–282
3. Akache B, Stark FC, Jia Y, Deschatelets L,
Dudani R, Harrison BA, Agbayani G,
Williams D, Jamshidi MP, Krishnan L et al
(2018) Sulfated archaeol glycolipids: comparison with other immunological adjuvants in
mice. PLoS One 13:e0208067
4. Calarota SA, Baldanti F (2013) Enumeration
and characterization of human memory T cells
by enzyme-linked immunospot assays. Clin
Dev Immunol 2013:637649
5. Jia Y, Akache B, Deschatelets L, Qian H,
Dudani R, Harrison BA, Stark FC,
Chandan V, Jamshidi MP, Krishnan L et al
(2019) A comparison of the immune responses
induced by antigens in three different
archaeosome-based vaccine formulations. Int
J Pharm 561:187–196
6. Plotkin SA (2008) Vaccines: correlates of
vaccine-induced immunity. Clin Infect Dis
47:401–409
7. Currier JR, Kuta EG, Turk E, Earhart LB,
Loomis-Price L, Janetzki S, Ferrari G, Birx
DL, Cox JH (2002) A panel of MHC class I
restricted viral peptides for use as a quality
control for vaccine trial ELISPOT assays. J
Immunol Methods 260:157–172
8. Junker N, Thor SP, Andersen MH, Svane IM
(2011) Characterization of ex vivo expanded
tumor infiltrating lymphocytes from patients
with malignant melanoma for clinical application. J Skin Cancer 2011:574695
9. Patton K, Aslam S, Lin J, Yu L, Lambert S,
Dawes G, Esser MT, Woo J, Janetzki S, Cherukuri A (2014) Enzyme-linked immunospot
assay for detection of human respiratory syncytial virus f protein-specific gamma interferonproducing T cells. Clin Vaccine Immunol
21:628–635
10. Britten CM, Walter S, Janetzki S (2013)
Immunological monitoring to rationally guide
AAV gene therapy. Front Immunol 4:273
11. Stevenson PG (2020) Immune control of
gamma-Herpesviruses. Viral Immunol 33
(3):225–232
12. Slota M, Lim JB, Dang Y, Disis ML (2011)
ELISpot for measuring human immune
responses to vaccines. Expert Rev Vaccines
10:299–306
13. Mobs C, Schmidt T (2016) Research techniques made simple: monitoring of T-cell subsets
using the ELISPOT assay. J Invest Dermatol
136:e55–e59
536
Bassel Akache and Michael J. McCluskie
1. Klimpel GR (1996) Immune Defenses. In:
Baron S, ed. Medical Microbiology. 4th
ed. Galveston (TX): University of Texas Medical Branch at Galveston, https://pubmed.ncbi.
nlm.nih.gov/21413332/
2. Cox JH, Ferrari G, Janetzki S (2006) Measurement of cytokine release at the single cell level
using the ELISPOT assay. Methods
38:274–282
3. Akache B, Stark FC, Jia Y, Deschatelets L,
Dudani R, Harrison BA, Agbayani G,
Williams D, Jamshidi MP, Krishnan L et al
(2018) Sulfated archaeol glycolipids: comparison with other immunological adjuvants in
mice. PLoS One 13:e0208067
4. Calarota SA, Baldanti F (2013) Enumeration
and characterization of human memory T cells
by enzyme-linked immunospot assays. Clin
Dev Immunol 2013:637649
5. Jia Y, Akache B, Deschatelets L, Qian H,
Dudani R, Harrison BA, Stark FC,
Chandan V, Jamshidi MP, Krishnan L et al
(2019) A comparison of the immune responses
induced by antigens in three different
archaeosome-based vaccine formulations. Int
J Pharm 561:187–196
6. Plotkin SA (2008) Vaccines: correlates of
vaccine-induced immunity. Clin Infect Dis
47:401–409
7. Currier JR, Kuta EG, Turk E, Earhart LB,
Loomis-Price L, Janetzki S, Ferrari G, Birx
DL, Cox JH (2002) A panel of MHC class I
restricted viral peptides for use as a quality
control for vaccine trial ELISPOT assays. J
Immunol Methods 260:157–172
8. Junker N, Thor SP, Andersen MH, Svane IM
(2011) Characterization of ex vivo expanded
tumor infiltrating lymphocytes from patients
with malignant melanoma for clinical application. J Skin Cancer 2011:574695
9. Patton K, Aslam S, Lin J, Yu L, Lambert S,
Dawes G, Esser MT, Woo J, Janetzki S, Cherukuri A (2014) Enzyme-linked immunospot
assay for detection of human respiratory syncytial virus f protein-specific gamma interferonproducing T cells. Clin Vaccine Immunol
21:628–635
10. Britten CM, Walter S, Janetzki S (2013)
Immunological monitoring to rationally guide
AAV gene therapy. Front Immunol 4:273
11. Stevenson PG (2020) Immune control of
gamma-Herpesviruses. Viral Immunol 33
(3):225–232
12. Slota M, Lim JB, Dang Y, Disis ML (2011)
ELISpot for measuring human immune
responses to vaccines. Expert Rev Vaccines
10:299–306
13. Mobs C, Schmidt T (2016) Research techniques made simple: monitoring of T-cell subsets
using the ELISPOT assay. J Invest Dermatol
136:e55–e59
536
Bassel Akache and Michael J. McCluskie